Intl Stem Cell Corp (ISCO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Sales | 9,100 | 9,085 | 7,789 | 8,180 | 7,176 |
| Cost of Goods | 4,033 | 3,764 | 3,181 | 3,269 | 2,935 |
| Gross Profit | 5,067 | 5,321 | 4,608 | 4,911 | 4,241 |
| Operating Expenses | 5,367 | 6,153 | 5,452 | 5,363 | 7,097 |
| Operating Income | -267 | -68 | -663 | -183 | -1,921 |
| Interest Expense | 151 | 145 | 139 | 135 | 128 |
| Other Income | 0 | 4 | 671 | -13 | 1,150 |
| Pre-tax Income | -418 | -209 | -131 | -331 | -899 |
| Net Income Continuous | -418 | -209 | -131 | -331 | -899 |
| Net Income | $-418 | $-209 | $-131 | $-331 | $-899 |
| EPS Basic Total Ops | -0.05 | -0.03 | -0.02 | -0.04 | -0.11 |
| EPS Basic Continuous Ops | -0.05 | -0.03 | -0.02 | -0.04 | -0.11 |
| EPS Diluted Total Ops | -0.05 | -0.03 | -0.02 | -0.04 | -0.11 |
| EPS Diluted Continuous Ops | -0.05 | -0.03 | -0.02 | -0.04 | -0.11 |
| EPS Diluted Before Non-Recurring Items | -0.05 | -0.03 | -0.02 | N/A | -0.20 |
| EBITDA(a) | $-48 | $138 | $-469 | $35 | $-1,659 |